Related Experiment Video
Updated: Jan 30, 2026

Labeling and Imaging of Amyloid Plaques in Brain Tissue Using the Natural Polyphenol Curcumin
Published on: November 1, 2019
The curcumin analog EF24 is a novel senolytic agent
Wen Li1,2,3, Yonghan He2, Rongping Zhang1
1School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, Yunnan 650500, China.
Curcumin analog EF24 effectively eliminates senescent cells, a key factor in aging and disease. This novel senolytic agent works by promoting apoptosis and degrading protective proteins, offering potential for age-related disease treatments.
Area of Science:
- Gerontology
- Molecular Biology
- Pharmacology
Background:
- Cellular senescence, characterized by the accumulation of senescent cells (SCs), is a significant aging hallmark and contributor to age-related diseases.
- Selective elimination of SCs is a promising therapeutic strategy for age-related conditions and healthspan extension.
- Curcumin analogs exhibit anti-aging properties, but their precise mechanisms remain unclear.
Purpose of the Study:
- To investigate the senolytic potential of various curcumin analogs.
- To elucidate the mechanism of action for senolytic curcumin analogs.
- To identify potent senolytic compounds for treating age-related diseases.
Main Methods:
- Screening of diverse curcumin analogs for senolytic activity.
- Investigating the mechanism of senolysis induced by EF24, including reactive oxygen species (ROS) production and protein degradation pathways.
- Assessing the synergistic effects of EF24 with known senolytic agents like ABT-263.
Main Results:
- EF24 demonstrated potent and broad-spectrum senolytic activity, selectively inducing apoptosis in senescent cells.
- EF24-induced senolysis was independent of ROS production but involved increased proteasome degradation of anti-apoptotic Bcl-2 family proteins.
- EF24 exhibited synergistic senolytic effects when combined with ABT-263.
Conclusions:
- Curcumin analog EF24 functions as a potent senolytic agent.
- The mechanism involves promoting apoptosis via degradation of anti-apoptotic proteins, independent of ROS.
- EF24 holds potential as a novel therapeutic agent for age-related diseases.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Subviral Agents
Air-entraining Agents
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Oral Hypoglycemic Agents: Glinides

